I didn't see this posted anywhere on any of my feeds (tweets, news, etc.)
Also they have an ATM in which they have used 13.5M of 20M available. That can squash any good news like yesterday also. Hmmmmmmmm. Have to rethink. Hmmm rethinking hurts...
EnteroMedics, Inc. (NASDAQ: ETRM) reported Q4 EPS of ($0.11), versus ($0.17) reported last year. Revenue for the quarter came in at $0 , versus $0 reported last year.
On December 31, 2013, the Company's cash, cash equivalents and short-term investments totaled $23.3 million, which includes approximately $11.0 million raised through the Company's "at-the-market" (ATM) equity facility. As of February 11, 2014 the Company has raised a total of approximately $13.5 million under its $20.0 million ATM equity facility.
"As we announced early today, the U.S. FDA has scheduled an Advisory Panel meeting for May 29, 2014 to review our PMA application for approval of the Maestro System," said Greg S. Lea, Senior Vice President, Chief Financial Officer and Chief Operating Officer. "Our primary focus remains on the regulatory process for VBLOC Therapy and preparing for a positive approval decision by FDA shortly after the Advisory Panel meeting."
These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.